Macrophage Markers Market
完整報告名稱與涵蓋範圍
Macrophage Markers Market Size, Share & Trends Analysis Report By Marker Type (CD68, CD163, CD206, CD14, CD11b, CD64, CD11c, Others), By Application (Research Use, Diagnostic Use and Drug Development), By Disease Area (Oncology, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases, Neurological Disorders, Others), By End User, By Region, And By Segment Forecasts, 2023-2031
報告摘要
Valued at USD 240.64 Million as of 2022, the global Macrophage Markers Market is forecasted to climb to USD 439.65 Million by 2031, reflecting a compound annual growth rate of 7.11% over the 2023–2031 period.
The Macrophage Markers sector involves distinct molecules or proteins utilized for identifying and characterising macrophages, a particular type of immune cell responsible for guarding the body against infections and. This domain has witnessed marked transformation owing to technological breakthroughs and shifting healthcare dynamics.
Market momentum is bolstered by expanding interest in advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region forecasted to deliver the strongest growth trajectory through the forecast period, bolstered by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Macrophage Marker Market Snapshot
Chapter 4. Global Macrophage Marker Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Marker Type Estimates & Trend Analysis
5.1. By Marker Type, & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Marker Type:
5.2.1. CD68
5.2.2. CD163
5.2.3. CD206
5.2.4. CD14
5.2.5. CD11b
5.2.6. CD64
5.2.7. CD11c
5.2.8. Others
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Application:
6.2.1. Research Use
6.2.2. Diagnostic Use
6.2.3. Drug Development
Chapter 7. Market Segmentation 3: By Disease Area Estimates & Trend Analysis
7.1. By Disease Area & Market Share, 2019 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Disease Area:
7.2.1. Oncology
7.2.2. Infectious Diseases
7.2.3. Autoimmune Diseases
7.2.4. Cardiovascular Diseases
7.2.5. Neurological Disorders
7.2.6. Others
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. By End User & Market Share, 2019 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By End User:
8.2.1. Research Institutes and Academic Centers
8.2.2. Pharmaceutical and Biotechnology Companies
8.2.3. Clinical and Diagnostic Laboratories
8.2.4. Others
Chapter 9. Macrophage Marker Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Macrophage Marker Market revenue (US$ Million) estimates and forecasts By Marker Type, 2023-2031
9.1.2. North America Macrophage Marker Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031
9.1.3. North America Macrophage Marker Market revenue (US$ Million) estimates and forecasts By Disease Area, 2023-2031
9.1.4. North America Macrophage Marker Market revenue (US$ Million) estimates and forecasts By End User, 2023-2031
9.1.5. North America Macrophage Marker Market revenue (US$ Million) estimates and forecasts by country, 2023-2031
9.2. Europe
9.2.1. Europe Macrophage Marker Market revenue (US$ Million) By Marker Type, 2023-2031
9.2.2. Europe Macrophage Marker Market revenue (US$ Million) By Application, 2023-2031
9.2.3. Europe Macrophage Marker Market revenue (US$ Million) By Disease Area, 2023-2031
9.2.4. Europe Macrophage Marker Market revenue (US$ Million) By End User, 2023-2031
9.2.5. Europe Macrophage Marker Market revenue (US$ Million) by country, 2023-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Macrophage Marker Market revenue (US$ Million) By Marker Type, 2023-2031
9.3.2. Asia Pacific Macrophage Marker Market revenue (US$ Million) By Application, 2023-2031
9.3.3. Asia Pacific Macrophage Marker Market revenue (US$ Million) By Disease Area, 2023-2031
9.3.4. Asia Pacific Macrophage Marker Market revenue (US$ Million) By End User, 2023-2031
9.3.5. Asia Pacific Macrophage Marker Market revenue (US$ Million) by country, 2023-2031
9.4. Latin America
9.4.1. Latin America Macrophage Marker Market revenue (US$ Million) By Marker Type, (US$ Million) 2023-2031
9.4.2. Latin America Macrophage Marker Market revenue (US$ Million) By Application, (US$ Million) 2023-2031
9.4.3. Latin America Macrophage Marker Market revenue (US$ Million) By Disease Area, (US$ Million) 2023-2031
9.4.4. Latin America Macrophage Marker Market revenue (US$ Million) By End User, (US$ Million) 2023-2031
9.4.5. Latin America Macrophage Marker Market revenue (US$ Million) by country, 2023-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Macrophage Marker Market revenue (US$ Million) By Marker Type, (US$ Million) 2023-2031
9.5.2. Middle East & Africa Macrophage Marker Market revenue (US$ Million) By Application, (US$ Million) 2023-2031
9.5.3. Middle East & Africa Macrophage Marker Market revenue (US$ Million) By Disease Area, (US$ Million) 2023-2031
9.5.4. Middle East & Africa Macrophage Marker Market revenue (US$ Million) By End User, (US$ Million) 2023-2031
9.5.5. Middle East & Africa Macrophage Marker Market revenue (US$ Million) by country, 2023-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Abcam plc,
10.2.2. Bio-Rad Laboratories, Inc.,
10.2.3. Cell Signaling Technology, Inc.,
10.2.4. BD Biosciences,
10.2.5. Thermo Fisher Scientific, Inc.,
10.2.6. Agilent Technologies, Inc.,
10.2.7. BioLegend, Inc.,
10.2.8. Merck KGaA,
10.2.9. Novus Biologicals, LLC,
10.2.10. R&D Systems, Inc. (a Bio-Techne brand),
10.2.11. Santa Cruz Biotechnology, Inc.,
10.2.12. Beckman Coulter, Inc.,
10.2.13. Miltenyi Biotec GmbH,
10.2.14. GeneTex, Inc.,
10.2.15. MBL International Corporation
10.2.16. Others
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們